| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.14 | 0.002 |